Clinical Research

Rophibio Inc.

Address
Room 406 194-25 Osongsaengmyeong 1-Ro

Sponsor Overview

assignment
1
sponsored trial
science
2
molecules
location_city
30
research centres
public
4
countries
person_search
30
investigators

Specializations

Retinal Disease Research

Rophibio Inc. is involved in clinical research focused on neovascular age-related macular degeneration, a leading cause of vision loss associated with abnormal blood vessel growth in the retina.

  • Age-related macular degeneration
  • Retinal vascular disorders
  • Macular pathology

The sponsor’s activity is centered on treatments intended to address visual impairment linked to macular degeneration and related retinal damage.

Ophthalmology and Vision Care

The company’s clinical research interests are concentrated in ophthalmology, particularly conditions affecting central vision and retinal function.

  • Visual acuity
  • Macular edema
  • Retinal imaging endpoints

Its trial portfolio reflects a therapeutic focus on preserving and improving sight in patients with degenerative eye disease.

Anti-VEGF Therapeutic Development

Rophibio Inc. is active in research on anti-VEGF therapy for retinal diseases driven by pathological angiogenesis and fluid leakage.

  • Angiogenesis inhibition
  • Intravitreal therapy
  • Ocular biologics

This area of interest is closely tied to treatments designed to reduce abnormal retinal vessel activity in nAMD.

Comparative Efficacy in Eye Treatments

The sponsor’s clinical work includes evaluation of efficacy, safety, and tolerability in ophthalmic therapy, with attention to visual outcome measures.

  • Best-corrected visual acuity
  • ETDRS letter score
  • Treatment comparability

Its research activity is directed toward assessing therapeutic performance in patients requiring ongoing management of retinal disease.

Sponsored Trials

Trial Name Country Status
Phase 3 Trial Comparing Efficacy, Safety, and Immunogenicity of Aflibercept (RBS-001) Versus Aflibercept in Neovascular Age-Related Macular DegenerationBulgaria BulgariaCroatia CroatiaPoland PolandSlovakia SlovakiaNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 2 total (0% not shared with other sponsors)

This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 30 sites collaborated multiple times

This sponsor has worked with 30 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Eye Diseases1 trial
    138 other sponsors

Partnered Research Centres

30 centres
location_city
assignment11
Caminomed Sp. z o.o.
Address
Ul. Kardynala Stefana Wyszynskiego 3a, 42-600 Tarnowskie Gory
Learn morearrow_forward
location_city
assignment19
Centrum Diagnostyki I Mikrochirurgii Oka Lens Sp. z o.o.
Address
Ul. Budowlana 3a, 10-424 Olsztyn
Learn morearrow_forward
location_city
assignment11
Centrum Medyczne Dietla 19 Sp. z o.o.
Address
Ul. Jozefa Dietla 19/3, 31-070 Krakow
Learn morearrow_forward
location_city
assignment51
Clinical Medical Center Osijek
Address
Europska Avenija 14, 31000 Osijek
Learn morearrow_forward
location_city
assignment2
Como Centrum Okulistyki Sp. z o.o.
Address
Ul. Katowa 10, 31-404 Krakow
Learn morearrow_forward
location_city
assignment65
F D Roosevelt University General Hospital Of Banska Bystrica
Address
Namestie Ludvika Svobodu 1, 974 01 Banská Bystrica
Learn morearrow_forward
Page 1 of 5

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Rophibio Inc..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.